By Michael Balsamo and Ann D'Innocenzio

The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.

The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.

The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.

Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.

“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”

The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.

AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.

The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.

In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.

Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.

The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.

Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.

Updated on December 22, 2020, at 3:44 p.m. ET with additional details.

Share:
More In Business
'Z2 Comics' Allows Musicians to Create Unique Stories
Live music took a big hit last year, and many artists had to cancel or postpone their tours to 2022. Many partnered with the graphic novel company Z2 Comics to make money by creating unique comic book stories. Josh Bernstein, executive vice president of Z2 Comics, and Sridhar Reddy, founder and publisher at Z2 Comics, join Cheddar News to talk about the company's popularity.
Starbucks Workers in Buffalo, NY, Vote to Unionize
Employees at a Buffalo, NY, area Starbucks voted to establish a union due to ongoing staffing issues, demands for higher pay, and complaints about non-functioning equipment. The development could clear the path for other locations across the country to unionize.
Lululemon Q3 Sees Growth in Men's Athleisure Sales but Mirror Sales Outlook Slashed
Caleb Silver, Investopedia Editor-in-Chief, joined Cheddar to break down Lululemon's Q3 earnings beat. Men's sales drove revenue up over the quarter, a key area that the company would want to grow, Silver said. He also noted that its $500 million acquisition of at-home fitness startup company Mirror could be a detriment for the company with its sales outlook slashed as more people head back into physical gyms and supply chain disruptions continue.
VMG Acquisition Corp. Lists on NASDAQ Under 'VMGAU'
VMG Consumer Acquisition Corp, a blank check company targeting consumer and retail companies, has officially hit Wall Street. The company listed its $200 million IPO on the NASDAQ, trading under the ticker symbol 'VMGAU.' Aarti Kapoor, CEO of VMG Consumer Acquisition Corp, joined Cheddar Movers to discuss.
Lime Connect Team Wins Goldman Sachs' Analyst Impact Fund
Goldman Sachs is getting into the holiday giving spirit with its sixth annual Analyst Impact Fund competition. The Shark-Tank style contest gives Junior Analysts the chance to pitch a charity of their choice to senior leadership, with the winner being granted $250,000 to donate to their chosen non-profit. The team representing Lime Connect, the world's largest network of people with disabilities, has taken home this year's top prize. For more on this, Jim Esposito, Goldman Sachs Co-Head of the Investment Banking Division, and Julian Sanchez, one of this year's winners, joined Cheddar Movers.
Load More